Issue

ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize Option

Retrieved on: 
Wednesday, March 20, 2024
Brussels Stock Exchange, SCI, Public, Private, KBC, VWAP, ARC, Hand, Acceleration, Regulation, DSM-IV codes, CSO, Movement, EUR, Private placement, BCI, Offerings, Public offering, Equity carve-out, Euronext, Issue, Euronext Amsterdam, Security (finance)

The final number of New Shares placed and the issue price per New Share (the “Issue Price”) will be announced after pricing of the Offerings.

Key Points: 
  • The final number of New Shares placed and the issue price per New Share (the “Issue Price”) will be announced after pricing of the Offerings.
  • The New Shares will be issued from the Company’s authorized capital under exclusion of the existing shareholders’ pre-emptive rights.
  • “It is the Company’s intention to raise gross proceeds of indicatively EUR 15 million from the Offerings, with an up to EUR 5 million upsize option.
  • A separate announcement will be made shortly regarding the Public Offer in France via the PrimaryBid platform and its terms.

ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize Option

Retrieved on: 
Wednesday, March 20, 2024
Failure, Economy, Brussels Stock Exchange, Exercise, Patient, Risk, European, Intellectual property, Marketing, SCI, Annual, Public, Private, KBC, AFM, Prospectus, Royal Victorian Order, VWAP, ARC, Hand, Acceleration, Part, Research, Classification, Enrollment, Certification, DSM-IV codes, CSO, FDA, Movement, Engineering, EUR, Private placement, BCI, Offerings, Public offering, Market, Issue, Euronext Amsterdam, Probability, Security (finance)

The Issue Price will be determined by the accelerated book-building initiated with institutional investors.

Key Points: 
  • The Issue Price will be determined by the accelerated book-building initiated with institutional investors.
  • The Public Offering will not extent to retail investors located outside of France.
  • The New Shares will be issued from the Company’s authorized capital under exclusion of the existing shareholders’ pre-emptive rights.
  • It is the Company’s intention to raise gross proceeds of approximately €15.0 million from the Offerings, with an up to €5 million upsize option.

PhRMA Secretly Funds Campaign to Kill Rent Control, per Justice for Renters

Retrieved on: 
Thursday, April 4, 2024
AIDS, Health, Consumer, Public Policy, Government, Residential Building & Real Estate, Pharmaceutical, Advocacy Group Opinion, Professional Services, Construction & Property, Environmental, Social and Governance (ESG), General Health, Seniors, State, Local, Other Policy Issues, Issue, AIDS Healthcare Foundation, Risk, Patient, Greater Los Angeles, Housing, Justice, Big Pharma, AHF, Pharmacy, Advertising, Property management

This latest move is part of an ongoing shell game carried out by PhRMA and the pharmaceutical companies it represents to avoid public scrutiny, including that of the press.

Key Points: 
  • This latest move is part of an ongoing shell game carried out by PhRMA and the pharmaceutical companies it represents to avoid public scrutiny, including that of the press.
  • “This is a shining example of how corporate greed puts both patients and tenants at risk,” said Susie Shannon, campaign manager for Justice for Renters .
  • PhRMA has a PAC called the Pharmaceutical Research and Manufacturers of America California Initiative Fund.
  • That PAC contributed an initial $10,000 to the California Business Roundtable PAC, which in turn contributed $250,000 to Californians to Protect Affordable Housing, a PAC opposing the Justice for Renters Act.

Six Lanier Law Firm Attorneys Honored Among State’s Top Young Lawyers

Retrieved on: 
Thursday, March 21, 2024
Professional Services, Legal, Business, Issue, Thomson Reuters, Personal injury, Lawyer, Asbestos, Steven Naifeh, Supreme court, Bard, Johnson & Johnson, Supreme

The Lanier Law Firm is pleased to announce that firm attorneys Jonathan Armour , Natalie Armour , Ryan Ellis , Caroline McLeod, Rebecca Phillips, and Christopher Phipps have been named among the state’s top young lawyers on the 2024 list of Texas Rising Stars.

Key Points: 
  • The Lanier Law Firm is pleased to announce that firm attorneys Jonathan Armour , Natalie Armour , Ryan Ellis , Caroline McLeod, Rebecca Phillips, and Christopher Phipps have been named among the state’s top young lawyers on the 2024 list of Texas Rising Stars.
  • The six from the Lanier Law Firm represent the largest number of firm attorneys selected since the inception of the list in 2004.
  • In addition to his litigation expertise, he is also a trained mediator with experience mediating cases on matters including contract and family law.
  • Ms. McLeod joined the Issues and Appeals section of The Lanier Law Firm in 2018.

Bitcoin Well Announces Brokered Financing Led by Haywood Securities

Retrieved on: 
Monday, March 4, 2024
Bitcoin, Well, Issuer, WIRE, TSX Venture Exchange, Marketing, Part, Sale, Date, Indian stock exchange, NOT, National instrument, NEWS, Issue, Offering, Prospectus, Security (finance)

EDMONTON, Alberta, March 04, 2024 (GLOBE NEWSWIRE) --  Bitcoin Well Inc. (“Bitcoin Well” or the “Company”) (TSXV: BTCW; OTCQB: BCNWF), the non-custodial bitcoin business on a mission to enable independence, is pleased to announce that it has entered into an agreement with Haywood Securities Inc. (“Haywood”) dated February 29, 2024 to act as sole agent and sole bookrunner to assist the Company in selling on a commercially reasonable efforts private placement basis, units of the Company (each, a “Unit”) at a price of C$0.175 per Unit (the “Issue Price”) for gross proceeds of a minimum of C$1,250,000 (from the sale of a minimum 7,142,857 Units) and a maximum of C$2,100,000 (from the sale of a maximum of 12,000,000 Units) (the “Offering”).

Key Points: 
  • The Company intends to use the net proceeds of the Offering for sales and marketing, working capital and general corporate purposes.
  • The securities offered under the Listed Issuer Financing Exemption will not be subject to a statutory hold period in accordance with applicable Canadian securities laws.
  • All securities not issued pursuant to the Listed Issuer Financing Exemption will be subject to a hold period in accordance with applicable Canadian securities law, expiring four months and one day following the Closing Date.
  • The Company expects to close the Offering on or about March 22, 2024, or such other date as the Company and Haywood may agree.

IsoEnergy Announces Upsize in Bought Deal Private Placement to $20 Million

Retrieved on: 
Friday, January 19, 2024
ISO, Underwriting, Issue, Offering, CEE, TSX Venture Exchange, News, Life insurance

The Company has granted the Underwriters an option to purchase for resale up to an additional 15% of the Premium FT Shares at the Issue Price (the “Over-Allotment Option”).

Key Points: 
  • The Company has granted the Underwriters an option to purchase for resale up to an additional 15% of the Premium FT Shares at the Issue Price (the “Over-Allotment Option”).
  • The Over-Allotment Option will be exercisable in whole or in part, up to 48 hours prior to the closing date of the Offering.
  • In connection with the Offering, the Underwriters will receive a cash commission equal to 6.0% of the gross proceeds of the Offering.
  • This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

IsoEnergy Announces C$15 Million Bought Deal Private Placement

Retrieved on: 
Thursday, January 18, 2024
ISO, Underwriting, Issue, Offering, CEE, TSX Venture Exchange, News, Life insurance

The Company has granted the Underwriters an option to purchase for resale up to an additional 15% of the Premium FT Shares at the Issue Price (the “Over-Allotment Option”).

Key Points: 
  • The Company has granted the Underwriters an option to purchase for resale up to an additional 15% of the Premium FT Shares at the Issue Price (the “Over-Allotment Option”).
  • The Over-Allotment Option will be exercisable in whole or in part, up to 48 hours prior to the closing date of the Offering.
  • In connection with the Offering, the Underwriters will receive a cash commission equal to 6.0% of the gross proceeds of the Offering.
  • This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

Result of General Meeting, Result of Offer for Subscription and Total Voting Rights

Retrieved on: 
Saturday, December 30, 2023
Incoming, Disclosure, Circular, GM, FCA, Official List, CREST, Admission, Treasury, Issue, Euronext Dublin, Resolution, London Stock Exchange, Security (finance)

As a result of the passing of the Resolution, the Company now has the requisite shareholder authority to complete the Placing, Subscription, Retail Offer and Offer for Subscription (the "Issue").

Key Points: 
  • As a result of the passing of the Resolution, the Company now has the requisite shareholder authority to complete the Placing, Subscription, Retail Offer and Offer for Subscription (the "Issue").
  • Accordingly, 21,261,548 New Ordinary Shares will be issued pursuant to the Issue at 270 pence each, raising gross proceeds of £57.4 million.
  • Admission is expected to become effective, and dealings to commence in the New Ordinary Shares, at 8.00 a.m. on 15 December 2023.
  • Following Admission, the Company will have 174,261,401 Ordinary Shares in issue with each share carrying the right to one vote.

Results of PrimaryBid Offer

Retrieved on: 
Thursday, December 21, 2023
ANY, NAV, NOT, Issue, Official List, London Stock Exchange, The, FOR, Annual general meeting, Admission, Resolution, GRW, Euronext Dublin, Mass meeting, Fundraising, FCA, LON, Circular, Security (finance), Subscription business model

Molten Ventures plc (LON: GROW, Euronext Dublin: GRW) announced on 27 November 2023 the launch of a fundraise comprising a placing (the "Placing") and subscription (the "Subscription") in conjunction with an offer via PrimaryBid (the "PrimaryBid Offer") (together the "Fundraise") alongside an Offer for Subscription (together with the Fundraise, the "Issue").

Key Points: 
  • Molten Ventures plc (LON: GROW, Euronext Dublin: GRW) announced on 27 November 2023 the launch of a fundraise comprising a placing (the "Placing") and subscription (the "Subscription") in conjunction with an offer via PrimaryBid (the "PrimaryBid Offer") (together the "Fundraise") alongside an Offer for Subscription (together with the Fundraise, the "Issue").
  • The Company is pleased to announce that the PrimaryBid Offer successfully completed and closed at 3.00 p.m. yesterday.
  • A total of 888,888 New Ordinary Shares have been subscribed for at a price of 270 pence per New Ordinary Share (the "Issue Price") pursuant to the PrimaryBid Offer.
  • Following the successful closing of the PrimaryBid Offer, the Company has raised gross proceeds of £57.4 million via the Fundraise.

Government of Canada to support projects aimed at helping prevent and decrease substance use-related harms among young people

Retrieved on: 
Tuesday, November 28, 2023
Substance, Organization, Indigenous self-government in Canada, Research, Public Health Agency, The Honourable, Government, Icelandic, Issue, Mental health, School, Addiction, Pharmaceutical industry, Health

Many young people across Canada continue to face challenges with substance use.

Key Points: 
  • Many young people across Canada continue to face challenges with substance use.
  • The Government of Canada continues to take urgent action to help save lives and prevent harms from the toxic illegal drug supply as we work towards an end to this national public health crisis.
  • Organizations working closely with schools, or those serving youth populations disproportionately impacted by substance use-related harms, are encouraged to apply for funding.
  • Minister Saks announced the launch during her participation in the Canadian Centre on Substance Use and Addiction's Issues of Substance conference .